Satoru Taguchi Selected Research

Satoru Taguchi Research Topics

Disease

20	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2012
18	Carcinoma (Carcinomatosis) 12/2023 - 09/2013
16	Neoplasms (Cancer) 03/2024 - 07/2015
13	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2013
7	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 04/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2017
3	Sarcopenia 12/2023 - 06/2016
3	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2022 - 01/2020
2	Margins of Excision 01/2024 - 03/2023
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2023 - 10/2023
2	Pain (Aches) 10/2023 - 01/2023
2	Lymphatic Metastasis 01/2023 - 02/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2021
2	Testicular Neoplasms (Testicular Cancer) 04/2022 - 09/2011
2	Hydronephrosis 01/2022 - 10/2017
2	Chronic Renal Insufficiency 01/2022 - 02/2018
2	Melanoma (Melanoma, Malignant) 03/2019 - 01/2017
1	Disease Progression 10/2023
1	Leiomyosarcoma 07/2023
1	Hyperglycemia 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Overactive Urinary Bladder (Overactive Bladder) 01/2023
1	Frailty 10/2022
1	Ischemic Stroke 10/2022
1	Stroke (Strokes) 10/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2022
1	Hematuria 01/2022
1	Atherosclerosis 01/2022
1	Lower Urinary Tract Symptoms 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Ovarian Cysts (Ovarian Cyst) 01/2022
1	Cysts 05/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Adenocarcinoma 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 09/2020

Drug/Important Bio-Agent (IBA)

7	pembrolizumabIBA 12/2023 - 01/2021
7	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 07/2016
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
4	AndrogensIBA 10/2023 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 01/2023 - 02/2016
4	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 09/2013
4	AlbuminsIBA 01/2021 - 02/2016
3	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2023
3	enfortumab vedotinIBA 01/2024 - 12/2023
3	Tolvaptan FDA Link 02/2022 - 01/2020
2	Proton Pump InhibitorsIBA 03/2024 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 01/2023
2	Xanthine DehydrogenaseIBA 01/2022 - 01/2021
2	GlobulinsIBA 01/2021 - 08/2020
2	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2015
2	talimogene laherparepvecIBA 03/2019 - 01/2017
2	C-Reactive ProteinIBA 09/2017 - 01/2017
1	avelumabIBA 12/2023
1	LigandsIBA 12/2023
1	PlatinumIBA 12/2023
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2023
1	Leuprolide (Lupron)FDA LinkGeneric 10/2023
1	Goserelin (Zoladex)FDA Link 10/2023
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2023
1	Hormones (Hormone)IBA 10/2023
1	Prednisolone (Predate)FDA LinkGeneric 10/2023
1	mirabegronIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 11/2022
1	Gemcitabine FDA Link 11/2022
1	Troponin T (Troponin T1)IBA 10/2022
1	LipidsIBA 10/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022
1	Collagen Type I (Type I Collagen)IBA 08/2022
1	N 30IBA 01/2022
1	AntibodiesIBA 01/2022
1	NivolumabIBA 01/2022
1	Cystatin CIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Melanins (Melanin)IBA 05/2021
1	SynaptophysinIBA 01/2021
1	Chromogranin AIBA 01/2021
1	cabazitaxel FDA Link 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	TEMPOIBA 09/2020

Therapy/Procedure

16	Prostatectomy (Retropubic Prostatectomy) 01/2024 - 01/2014
9	Therapeutics 01/2024 - 10/2012
9	Drug Therapy (Chemotherapy) 12/2023 - 09/2013
8	Radiotherapy 01/2024 - 01/2015
6	Cystectomy 07/2023 - 01/2017
5	Nephroureterectomy 01/2022 - 02/2016
4	Castration 12/2023 - 01/2012
3	Transurethral Resection of Bladder 01/2022 - 01/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 11/2019
2	Adjuvant Chemotherapy 03/2023 - 10/2017
2	Immunotherapy 01/2023 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 01/2019
2	Oncolytic Virotherapy 03/2019 - 01/2017
1	Hysterectomy 01/2022
1	Ovariectomy (Oophorectomy) 01/2022
1	Brachytherapy 09/2020